There is a class action lawsuit related to the morning sickness drug Zofran. The lawsuit alleges that mothers who have taken Zofran during pregnancy to relieve morning sickness have experienced birth defects in their newborn babies. This is one of those class action lawsuits that has severe consequences on a number of levels.
Zofran was originally prescribed for people suffering very difficult effects of chemotherapy treatment. During the 1990’s, the company was able to effectively expand the scope and use of Zofran to include pregnant mothers experiencing morning sickness. The lawsuit alleges that not enough research and analysis was done to determine the safety of the expecting mother. The implication is that it was the result of another large drug company becoming overzealous and its desire to sell more prescribed drugs.